The Monovisc® 22 mg/ml pre-filled syringe is a medical device containing ultra-pure hyaluronan, indicated for the treatment of osteoarthritis of the knee, hip, shoulder and ankle joints.
€238.54
(May vary by country)
Ready to ship in 1-3 working days ⁴
The Monovisc® 22 mg/ml pre-filled syringe is a medical device containing ultra-pure hyaluronan, indicated for the treatment of osteoarthritis of the knee, hip, shoulder and ankle joints.
- Rapid and long-lasting pain relief: Outperforms conventional viscosupplements by halting the degenerative process and enabling a rapid return to everyday life.
- Unique cross-linking process: Long-lasting lubrication and demonstrably improved joint mobility thanks to the patented cross-linking process.
- Proven efficacy and safety:
Efficacy and safety confirmed by FDA studies, with a low rate of side effects.
Indications for MONOVISC®:
Osteoarthritis of the knee, hip, shoulder
and ankle
MONOVISC® is an FDA-approved viscosupplement made from ultra-pure, high-molecular-weight hyaluronan, a natural lubricant found in healthy joints. This non-avian product provides early and long-lasting pain relief with a single, highly concentrated injection. Its convenient 4-ml packaging simplifies administration for doctors and improves comfort for patients.
Dosage form
Pre-filled syringe
Usage
- Treatment with MONOVISC® requires only a single injection.
- Notes: Administration must only be carried out by qualified doctors.
Ingredients
Composition: MONOVISC® comprises a 4 ml injection containing 88 mg of cross-linked hyaluronic acid.
| Piece: | 1 |
|---|